The results show that HSE suppressed STAT5 DNA-binding activity in human breast cancer cells, and there was a dramatic loss of STAT3 binding to the promoter site in HSE treated MDA-MB 231 cells. The gene discussed is STAT5B; the disease is breast carcinoma.